SITE MAP   |   CONTACT US

Investor Relations




Current SEC Filings height=1height=1 Current SEDAR Filings

To receive email alerts whenever SEC filings are added to this website, please enter your email address below; then click 'Subscribe.'

Email:

Read Biovail's Privacy Policy

Tools

Investment Calculator


Email Alerts

Resources

Q3/2009 Financial Results

Biovail's Product Pipeline 

Pimavanserin Schizophrenia Co-Therapy - Phase 2 Data 

Aplenzin Prescribing Information

Nitoman Prescribing Information 

Xenazine Prescribing Information

Xenazine Medication Guide

Corporate Fact Sheet

IMPORTANT:  Income Tax Information for Canadian Resident Shareholders

 

 
 

Download Adobe Acrobat Reader

Events




© 2007 Biovail Corporation - All Rights Reserved (BIO113B0602) Privacy Policy   |   Disclaimers